Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 160

The DOI matches its Crossref record.

Long-Term Benefits of Highly Active Antiretroviral Therapy in Senegalese HIV-1-Infected Adults

Laurent, Christian, Ngom Gueye, Ndeye Fatou, Ndour, Cheikh Tidiane, Gueye, Pape Mandoumb??, Diouf, Martin, Diakhat??, Ndella, Tour?? Kane, Ndeye Coumba, Lani??ce, Isabelle, Ndir, Adama, Vergne, Laurence, Ndoye, Ibrahima, Mboup, Souleymane, Sow, Pape Salif, Delaporte, Eric·2005·JAIDS Journal of Acquired Immune Deficiency Syndromes

Abstract

OBJECTIVES: To assess the long-term survival, as well as the immunologic and virologic effectiveness, adherence, and drug resistance, in HIV-infected patients receiving highly active antiretroviral therapy (HAART) in one of the oldest and best-documented African cohorts. METHODS: A prospective observational cohort study included the first 176 HIV-1-infected adults followed in the Senegalese government-sponsored antiretroviral therapy initiative launched in August 1998. Patients were followed for a median of 30 months (interquartile range, 21-36 months). HAART comprised 2 nucleoside reverse transcriptase inhibitors and either 1 protease inhibitor or 1 nonnucleoside reverse transcriptase inhibitor. RESULTS: At baseline, 92% of patients were antiretroviral naive and 82% had AIDS; the median CD4 count was 144 cells/mm, and median viral load was 202,368 copies/mL. The survival probability was high (0.81 at 3 years; 95% CI, 0.74-0.86) and was independently related to a baseline hemoglobin level <10 g/dL and a Karnofsky score <90%. Antiviral efficacy was consistently observed during the 3 years of treatment (-2.5 to -3.0 log10 copies/mL; 60-80% of patients with viral load <500 copies/mL) and the CD4 count increase reached a median of 225 cells/mm. Most patients reported good adherence (80-90%). The emergence of drug resistance was relatively rare (12.5%). CONCLUSION: This study shows that clinical and biologic results similar to those seen in Western countries can be achieved and sustained during the long term in Africa.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1097/00126334-200501010-00003

Cites

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cited by

See all 160

Metadata

Authors
Laurent, C., Ngom Gueye, N. F., Ndour, C. T., Gueye, P. M., Diouf, M., Diakhat??, N., Tour?? Kane, N. C., Lani??ce, I., Ndir, A., Vergne, L., Ndoye, I., Mboup, S., Sow, P. S., & Delaporte, E.
Venue
JAIDS Journal of Acquired Immune Deficiency Syndromes
Published
2005-01
Volume
38
Issue
1
Pages
14-17
ISSN
1525-4135 (ISSN-L)
OpenAlex
W2094724488
Cited by
160
References
0
FWCI
10.59
Type
journal article
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Long-Term Benefits of Highly Active Antiretroviral Therapy in Senegalese HIV-1-Infected Adults. https://app.cochat.ai/papers/10.1097/00126334-200501010-00003
The paper
Laurent, C., Ngom Gueye, N. F., Ndour, C. T., Gueye, P. M., Diouf, M., Diakhat??, N., Tour?? Kane, N. C., Lani??ce, I., Ndir, A., Vergne, L., Ndoye, I., Mboup, S., Sow, P. S., & Delaporte, E. (2005). Long-Term Benefits of Highly Active Antiretroviral Therapy in Senegalese HIV-1-Infected Adults. JAIDS Journal of Acquired Immune Deficiency Syndromes. https://doi.org/10.1097/00126334-200501010-00003

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.